Clinical Trial Update: A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating immunogenicity of various schedules of an inactivated poliovirus vaccine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Inactivated Poliovirus Vaccine (IPV) (Inactivated Poliovirus Vaccine)

Snippet

Sponsor: Fidec Corporation | Conditions: Poliomyelitis | Phase 3 | Status: WITHDRAWN